Literature DB >> 20123826

Nonadherence to medication four years after a first episode of psychosis and associated risk factors.

Michele Hill1, Niall Crumlish, Petter Whitty, Mary Clarke, Stephen Browne, Moayyad Kamali, Anthony Kinsella, John L Waddington, Conall Larkin, Eadbhard O'Callaghan.   

Abstract

OBJECTIVES: This study examined concurrent associations and predictors at first indication of nonadherence to antipsychotic medication four years after a first episode of psychosis.
METHODS: A prospective cohort of 171 patients in urban Ireland with a first episode of psychosis was followed up four years after inception (follow-up primary analysis, N=84; secondary analysis, N=104).
RESULTS: At the four-year follow-up 76% were adherent and 24% were not. Nonadherence was concurrently associated with substance misuse (p<.01), increased symptomatology (p<.01), less insight (p=.01), lower global functioning (p<.01), and negative attitudes toward medication (p<.01). Compared with other patients, those who were nonadherent had more readmissions (p=.01). Predictors of future nonadherence were substance misuse (p=.02) and duration of untreated psychosis (p=.04).
CONCLUSIONS: This prospective investigation confirms previous cross-sectional studies. The association between longer duration of untreated psychosis and nonadherence warrants further research because it could be interpreted as further evidence of the importance of early intervention.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20123826     DOI: 10.1176/ps.2010.61.2.189

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  7 in total

1.  Medication adherence in first episode psychosis: the role of pre-onset subthreshold symptoms.

Authors:  J-G Daneault; A Maraj; M Lepage; A Malla; N Schmitz; S N Iyer; R Joober; J L Shah
Journal:  Acta Psychiatr Scand       Date:  2019-04       Impact factor: 6.392

2.  Modeling determinants of medication attitudes and poor adherence in early nonaffective psychosis: implications for intervention.

Authors:  Richard J Drake; Merete Nordentoft; Gillian Haddock; Celso Arango; W Wolfgang Fleischhacker; Birte Glenthøj; Marion Leboyer; Stefan Leucht; Markus Leweke; Phillip McGuire; Andreas Meyer-Lindenberg; Dan Rujescu; Iris E Sommer; René S Kahn; Shon W Lewis
Journal:  Schizophr Bull       Date:  2015-03-05       Impact factor: 9.306

3.  Mediating Effect Of The Motivation For Medication Use On Disease Management And Medication Adherence Among Community-Dwelling Patients With Schizophrenia.

Authors:  Wen Ling Hsieh; Shih Kai Lee; Wai Tong Chien; Wen I Liu; Chien Yu Lai; Chieh Yu Liu
Journal:  Patient Prefer Adherence       Date:  2019-11-05       Impact factor: 2.711

4.  Medication Adherence in a Cross-Diagnostic Sample of Patients From the Affective-to-Psychotic Spectrum: Results From the PsyCourse Study.

Authors:  Sophie-Kathrin Kirchner; Michael Lauseker; Kristina Adorjan; Heike Anderson-Schmidt; Ion-George Anghelescu; Bernhardt T Baune; Monika Budde; Udo Dannlowski; Detlef E Dietrich; Andreas J Fallgatter; Peter Falkai; Christian Figge; Katrin Gade; Urs Heilbronner; Lena Hiendl; Georg Juckel; Janos L Kalman; Farahnaz Klöhn-Saghatolislam; Carsten Konrad; Fabian U Lang; Mojtaba Oraki Kohshour; Sergi Papiol; Daniela Reich-Erkelenz; Jens Reimer; Eva Z Reininghaus; Sabrina K Schaupp; Max Schmauß; Andrea Schmitt; Eva Christina Schulte; Simon Senner; Carsten Spitzer; Thomas Vogl; Jörg Zimmermann; Alkomiet Hasan; Thomas G Schulze; Fanny Senner
Journal:  Front Psychiatry       Date:  2022-01-20       Impact factor: 4.157

5.  Cannabis use and involuntary admission may mediate long-term adherence in first-episode psychosis patients: a prospective longitudinal study.

Authors:  Sara Barbeito; Patricia Vega; Sonia Ruiz de Azúa; Margarita Saenz; Mónica Martinez-Cengotitabengoa; Itxaso González-Ortega; Cristina Bermudez; Margarita Hernanz; Blanca Fernández de Corres; Ana González-Pinto
Journal:  BMC Psychiatry       Date:  2013-12-01       Impact factor: 3.630

Review 6.  Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review.

Authors:  Marco Solmi; Andrea Murru; Isabella Pacchiarotti; Juan Undurraga; Nicola Veronese; Michele Fornaro; Brendon Stubbs; Francesco Monaco; Eduard Vieta; Mary V Seeman; Christoph U Correll; André F Carvalho
Journal:  Ther Clin Risk Manag       Date:  2017-06-29       Impact factor: 2.423

7.  Psychotropic medication non-adherence and its associated factors among patients with major psychiatric disorders: a systematic review and meta-analysis.

Authors:  Agumasie Semahegn; Kwasi Torpey; Adom Manu; Nega Assefa; Gezahegn Tesfaye; Augustine Ankomah
Journal:  Syst Rev       Date:  2020-01-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.